ENVOY MEDICAL, INC. Financing Cash Flow
ENVOY MEDICAL, INC. (COCH) reported Financing Cash Flow of $27.46 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-10
- ENVOY MEDICAL, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$109.00K, a 102.46% decline year-over-year.
- ENVOY MEDICAL, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $27.57M, a 675.86% increase year-over-year.
- ENVOY MEDICAL, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $6.04M, a 7.53% increase year-over-year.
- ENVOY MEDICAL, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $2.60M, a 56.04% decline year-over-year.
- ENVOY MEDICAL, INC. net cash provided by (used in) financing activities for fiscal 2023 was $21.28M, a 163.00% increase from fiscal 2022.
- ENVOY MEDICAL, INC. net cash provided by (used in) financing activities for fiscal 2022 was $8.09M, a 98.11% decline from fiscal 2021.
- ENVOY MEDICAL, INC. net cash provided by (used in) financing activities for fiscal 2021 was $428.37M.
| Period end | Net Cash Provided by (Used in) Financing Activities 0 month | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$109.00K derived: 10-Q 6 month − POS AM 3 month · filed 2026-08-10 | $27.46M 10-Q · filed 2026-08-10 | $33.51M derived: sum of 3 quarters · filed 2026-08-10 | $36.11M derived: sum of 4 quarters · filed 2026-08-10 | |||||
| 2026-03-31 | $27.57M POS AM · filed 2026-06-12 | $33.61M derived: sum of 2 quarters · filed 2026-06-12 | $36.22M derived: sum of 3 quarters · filed 2026-06-12 | $40.65M derived: sum of 4 quarters · filed 2026-08-10 | |||||
| 2025-12-31 | $6.04M derived: POS AM 12 month − 10-Q 9 month · filed 2026-06-12 | $8.64M derived: sum of 2 quarters · filed 2026-06-12 | $13.08M derived: sum of 3 quarters · filed 2026-08-10 | $16.63M POS AM · filed 2026-06-12 | |||||
| 2025-09-30 | $2.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $7.04M derived: sum of 2 quarters · filed 2026-08-10 | $10.59M 10-Q · filed 2025-11-10 | $16.21M derived: sum of 4 quarters · filed 2026-08-10 | |||||
| 2025-06-30 | $4.44M derived: 10-Q 6 month − POS AM 3 month · filed 2026-08-10 | $7.99M 10-Q · filed 2026-08-10 | $13.61M derived: sum of 3 quarters · filed 2026-08-10 | $19.53M derived: sum of 4 quarters · filed 2026-08-10 | |||||
| 2025-03-31 | $3.55M POS AM · filed 2026-06-12 | $9.17M derived: sum of 2 quarters · filed 2026-06-12 | $15.09M derived: sum of 3 quarters · filed 2026-06-12 | $17.33M derived: sum of 4 quarters · filed 2026-06-12 | |||||
| 2024-12-31 | $5.62M derived: POS AM 12 month − 10-Q 9 month · filed 2026-06-12 | $11.53M derived: sum of 2 quarters · filed 2026-06-12 | $13.77M derived: sum of 3 quarters · filed 2026-06-12 | $20.20M POS AM · filed 2026-06-12 | |||||
| 2024-09-30 | $5.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $8.15M derived: sum of 2 quarters · filed 2025-11-10 | $14.58M 10-Q · filed 2025-11-10 | $15.28M 10-Q · filed 2024-11-14 | $13.13M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | $2.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $8.66M 10-Q · filed 2025-07-31 | $9.18M 10-Q · filed 2024-08-12 | $7.21M derived: sum of 3 quarters · filed 2025-07-31 | $22.95M derived: sum of 4 quarters · filed 2025-07-31 | ||||
| 2024-03-31 | $6.43M 10-Q · filed 2025-05-01 | $6.68M 10-Q · filed 2024-05-15 | $4.97M derived: sum of 2 quarters · filed 2025-05-01 | $20.71M derived: sum of 3 quarters · filed 2025-05-01 | $23.71M derived: sum of 4 quarters · filed 2025-05-01 | ||||
| 2023-12-31 | -$1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $14.28M derived: sum of 2 quarters · filed 2025-03-31 | $17.28M derived: sum of 3 quarters · filed 2025-03-31 | $21.28M 10-K · filed 2025-03-31 | $21.84M 10-K · filed 2024-04-01 | ||||
| 2023-09-30 | $15.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $18.74M derived: sum of 2 quarters · filed 2024-11-14 | $22.74M 10-Q · filed 2024-11-14 | $24.74M derived: sum of 4 quarters · filed 2024-11-14 | |||||
| 2023-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $7.00M 10-Q · filed 2024-08-12 | -$386.42M 10-Q · filed 2023-08-14 | $9.00M derived: sum of 3 quarters · filed 2024-08-12 | $13.59M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | $4.00M 10-Q · filed 2024-05-15 | -$386.87M 10-Q · filed 2023-05-15 | $6.00M derived: sum of 2 quarters · filed 2024-05-15 | $10.59M derived: sum of 3 quarters · filed 2024-05-15 | $11.34M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $2.00M derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-04-01 | $6.59M derived: sum of 2 quarters · filed 2024-04-01 | $7.34M derived: sum of 3 quarters · filed 2024-04-01 | $8.09M 10-K · filed 2024-04-01 | $1.50M 10-K · filed 2023-04-03 | ||||
| 2022-09-30 | $4.59M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-01-17 | $5.34M derived: sum of 2 quarters · filed 2024-01-17 | $6.09M 10-Q/A · filed 2024-01-17 | $1.50M 10-Q · filed 2022-11-14 | $6.09M derived: sum of 4 quarters · filed 2024-01-17 | ||||
| 2022-06-30 | $750.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.50M 10-Q · filed 2023-08-14 | $1.50M derived: sum of 3 quarters · filed 2023-08-14 | $1.50M derived: sum of 4 quarters · filed 2023-08-14 | |||||
| 2022-03-31 | $750.00K 10-Q · filed 2023-05-15 | $753.00K derived: sum of 2 quarters · filed 2023-05-15 | $747.00K derived: sum of 3 quarters · filed 2023-05-15 | $5.74M derived: sum of 4 quarters · filed 2023-05-15 | |||||
| 2021-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-03 | -$3.00K derived: sum of 2 quarters · filed 2023-04-03 | $4.99M derived: sum of 3 quarters · filed 2023-04-03 | $428.37M 10-K · filed 2023-04-03 | |||||
| 2021-09-30 | -$6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $4.98M derived: sum of 2 quarters · filed 2022-11-14 | $428.36M 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | $4.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $428.37M 10-Q · filed 2022-08-15 | |||||||
| 2021-03-31 | $423.38M 10-Q · filed 2022-05-16 | ||||||||
| 2020-12-31 | $25.00K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| Bone Biologics Corp (BBLG) | United States | $0.001B | |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |